CTOs on the Move

Osiris Therapeutics

www.osiris.com

 
Osiris Therapeutics, Inc. is a leading stem cell company focused on developing and marketing products to treat medical conditions in the inflammatory, autoimmune, orthopedic and cardiovascular areas. Osiris’ stem cell products have significant therapeutic potential because of their ability to regulate inflammation, promote tissue regeneration and prevent pathological scar formation. In Biosurgery, we harness the ability of cells and novel constructs to promote the body`s natural healing. The goals are to improve surgical outcomes and offer better treatment options for patients and physicians. We like a challenge, so the focus is in areas where we believe we can have a ...
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million
  • www.osiris.com
  • 7015 Albert Einstein Dr
    Columbia, MD USA 21046
  • Phone: 443.545.1800

Executives

Name Title Contact Details

Similar Companies

Beitler-Mc Kee Optical Co

Beitler-Mc Kee Optical Co is a Pittsburgh, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

DURECT Corporation

DURECT Corporation is a Cupertino, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Hermann Medical Supply

Hermann Medical Supply is a Houston, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Flowcardia

Flowcardia is a Sunnyvale, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

MedicaMetrix

We are a startup up medical device company whose sole focus and mission are to transform patient care through innovative Med-tech solutions. Our initial product is a minimally invasive Prostate Volume Measurement Device to help doctors evaluate a patient`s prostate health. Our solution includes a controller that receives measurement data from an encoder device. The encoder a disposable, single-use component made with an injection molding process. We are in the proof of concept phase and want to move to test marketing trials and production by end of 2020.